InvestorsObserver
×
News Home

Is Myovant Sciences Ltd (MYOV) a Good Buy in the Biotechnology Industry?

Thursday, March 02, 2023 01:49 PM | InvestorsObserver Analysts

Mentioned in this article

Is Myovant Sciences Ltd (MYOV) a Good Buy in the Biotechnology Industry?

Myovant Sciences Ltd (MYOV) is around the top of the Biotechnology industry according to InvestorsObserver. MYOV received an overall rating of 62, which means that it scores higher than 62 percent of all stocks. Myovant Sciences Ltd also achieved a score of 74 in the Biotechnology industry, putting it above 74 percent of Biotechnology stocks. Biotechnology is ranked 48 out of the 148 industries.

Overall Score - 62
MYOV has an Overall Score of 62. Find out what this means to you and get the rest of the rankings on MYOV!

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.
This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Myovant Sciences Ltd Stock Today?

Myovant Sciences Ltd (MYOV) stock is flat -0.02% while the S&P 500 is higher by 0.04% as of 1:38 PM on Thursday, Mar 2. MYOV is unmoved $0.00 from the previous closing price of $26.96 on volume of 1,240,149 shares. Over the past year the S&P 500 is lower by -9.88% while MYOV is higher by 103.47%. MYOV lost -$1.92 per share the over the last 12 months. Click Here to get the full Stock Report for Myovant Sciences Ltd stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App